<DOC>
	<DOCNO>NCT02380534</DOCNO>
	<brief_summary>To evaluate effect H.E.L.P . apheresis lipid profile , Lp ( ) level , inflammatory adypocytokines patient high cardiovascular risk .</brief_summary>
	<brief_title>Use Apheretic Technologies Cardiovascular Disease</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>high Lp ( ) responsive diet pharmacological treatment heart failure hepatic failure renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>High level Lp ( )</keyword>
</DOC>